Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / SEEL - Mitsubishi Tanabe launches late-stage study in U.S. for continuous Parkinson's therapy

SEEL - Mitsubishi Tanabe launches late-stage study in U.S. for continuous Parkinson's therapy

Seelos Therapeutics Inc.
  • Mitsubishi Tanabe Pharma America (OTCPK:MTZPY -1.5%) initiates a Phase 3 clinical trial, BouNDless, evaluating continuous subcutaneously administered carbidopa/levodopa (ND0612) compared to the oral formulation in Parkinson's disease (PD) patients.
  • More news on: Mitsubishi Tanabe Pharma Corporation, Seelos Therapeutics, Inc., Kyowa Kirin Co., Ltd., Healthcare stocks news,
    • Read more ...
Stock Information
Company Name: Seelos Therapeutics Inc.
Stock Symbol: SEEL
Market: NYSE
Website: seelostherapeutics.com
Menu
SEEL SEEL Quote SEEL Short SEEL News SEEL Articles SEEL Message Board
Get SEEL Alerts

News, Short Squeeze, Breakout and More Instantly...